VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,405,610 | -17.3% | 1,482,780 | +26.2% | 0.01% | -9.1% |
| Q2 2023 | $7,741,734 | +7.2% | 1,174,770 | +10.4% | 0.01% | 0.0% |
| Q1 2023 | $7,223,942 | +22.8% | 1,063,909 | +33.6% | 0.01% | +10.0% |
| Q4 2022 | $5,883,615 | -12.6% | 796,159 | +16.9% | 0.01% | -9.1% |
| Q3 2022 | $6,731,000 | +18.0% | 681,229 | +30.1% | 0.01% | +22.2% |
| Q2 2022 | $5,706,000 | -1.2% | 523,479 | +2.5% | 0.01% | +12.5% |
| Q1 2022 | $5,776,000 | -29.1% | 510,704 | -1.7% | 0.01% | -20.0% |
| Q4 2021 | $8,151,000 | -26.5% | 519,554 | -19.7% | 0.01% | -33.3% |
| Q3 2021 | $11,086,000 | -33.2% | 646,755 | -16.1% | 0.02% | -34.8% |
| Q2 2021 | $16,586,000 | +25.9% | 771,112 | -12.1% | 0.02% | +15.0% |
| Q1 2021 | $13,178,000 | -2.5% | 877,346 | -14.7% | 0.02% | -13.0% |
| Q4 2020 | $13,515,000 | +35.1% | 1,028,476 | -0.7% | 0.02% | +21.1% |
| Q3 2020 | $10,002,000 | -35.3% | 1,035,453 | -23.3% | 0.02% | -34.5% |
| Q2 2020 | $15,451,000 | +16.9% | 1,350,613 | +5.9% | 0.03% | 0.0% |
| Q1 2020 | $13,218,000 | -36.4% | 1,275,911 | +0.8% | 0.03% | -6.5% |
| Q4 2019 | $20,770,000 | +64.0% | 1,265,697 | +32.7% | 0.03% | +55.0% |
| Q3 2019 | $12,667,000 | +155.7% | 953,900 | +171.3% | 0.02% | +150.0% |
| Q2 2019 | $4,954,000 | -21.9% | 351,541 | +1.9% | 0.01% | -27.3% |
| Q1 2019 | $6,345,000 | -63.8% | 344,851 | -48.6% | 0.01% | -64.5% |
| Q4 2018 | $17,547,000 | -3.6% | 671,506 | -15.4% | 0.03% | +14.8% |
| Q3 2018 | $18,211,000 | +15.1% | 793,502 | -4.4% | 0.03% | +12.5% |
| Q2 2018 | $15,816,000 | +10.7% | 830,239 | -2.1% | 0.02% | +9.1% |
| Q1 2018 | $14,285,000 | +33.5% | 847,779 | +20.4% | 0.02% | +46.7% |
| Q4 2017 | $10,701,000 | +1.5% | 704,009 | +19.5% | 0.02% | 0.0% |
| Q3 2017 | $10,543,000 | +11.2% | 588,978 | +1.3% | 0.02% | +7.1% |
| Q2 2017 | $9,478,000 | +10.2% | 581,488 | -5.3% | 0.01% | +7.7% |
| Q1 2017 | $8,600,000 | -11.5% | 614,318 | +0.8% | 0.01% | -18.8% |
| Q4 2016 | $9,723,000 | -2.4% | 609,618 | +1.9% | 0.02% | 0.0% |
| Q3 2016 | $9,959,000 | +151.4% | 598,518 | +69.0% | 0.02% | +128.6% |
| Q2 2016 | $3,962,000 | +413.9% | 354,108 | +642.7% | 0.01% | +600.0% |
| Q2 2014 | $771,000 | +8.0% | 47,677 | +8.6% | 0.00% | 0.0% |
| Q1 2014 | $714,000 | +31.2% | 43,908 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $544,000 | -42.6% | 43,808 | -49.2% | 0.00% | -50.0% |
| Q3 2013 | $947,000 | +80.4% | 86,308 | +32.8% | 0.00% | +100.0% |
| Q2 2013 | $525,000 | – | 65,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |